Hide Board Information

Show Board Information

Alerus Financial Corp ALRS

Board Mod: Add me as mod

Asst Mods:

Last Post: 04/19/2024 3:55:48 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 5

Alerus Financial Corp (OTCMRKTS: ALRS) Stock Message Board

1. ALRS Company Profile

    

2. ALRS Time & Sales

    

3. ALRS Recent News

    

4. ALRS Filings

    

5. ALRS Financials

    

6. ALRS Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

8	$ALRS News Article - When (ALRS) Moves Investors	whytestocks	04/19/2024 3:55:48 PM
7	$ALRS News Article - Alerus Financial Corporation	whytestocks	05/20/2022 12:25:49 PM
6	$ALRS News Article - Alerus Financial Corporation	whytestocks	07/01/2021 3:30:48 PM
5	$ALRS News Article - Alerus Acquires Retirement	whytestocks	12/18/2020 3:50:48 PM
4	ALRS Financials 07/15/2014 19:13:11 Alerus	Emylers	07/15/2014 8:13:09 PM
3	ALRS 49.25 Stock Charts $ALRS 1 Month Chart	chartguy89	03/05/2014 9:02:32 PM
2	ALRS Stock Charts Saturday, February 22, 2014 at	chartguy89	02/22/2014 7:54:25 AM
1	ALRS Stock Chart 49.50 Saturday, February 8, 2014	chartguy89	02/08/2014 4:01:29 AM

Recent Articles

• Critical Legal Actions Impacting Fiserv Investors This Year
• VineBrook Homes Trust Cancels Annual Stockholder Meeting
• Empowering REALTORS with Innovative Tools for Success
• Significant Growth of Laureate Education Stock Over Five Years
• ChoiceCash Launches Online Auto Equity Loans in Hawaii
• Investors May Drive Securities Fraud Class Action for Mutual Funds
• Oscar Health: Navigating the Storm in Health Insurance Market
• Discovering Hidden Gems: Stocks Beyond the S&P 500 Limelight
• ServiceNow Set to Disrupt with Its AI-Fueled Growth
• Empowering Real Estate Agents with New Partnership Tools
• Top Companies Driving the AI Infrastructure Expansion
• How Qualcomm is Shaping the Future of Technology Growth
• BlackRock Canada Announces Key Cash Distributions for ETFs
• The Remarkable Growth of Regeneron Pharmaceuticals Over Two Decades
• BlackRock Canada Provides Updates on iShares Cash Distributions
• Tivity Health: Important Class Action Details for Investors
• Understanding Copart Inc.'s Price-to-Earnings Ratio Dynamics
• VineBrook Homes Trust Cancels Annual Meeting: Key Insights
• Clearnetworx Expands Fiber Internet in Four Corners Area
• Investigation Into Nutex Health Inc. Potentially Misleading Info
• Understanding the Growth of Investment in Mosaic Over Time
• Legal Insight: Examining Recent Mergers of CEPO, EFIN, SQCF, TLGYF
• Investors Invited to Join Fiserv, Inc. Securities Action
• Brigham Young University Faces Investigation Over Data Breach
• Univest Securities Completes $4.2 Million Offering for GSIW
• Skechers U.S.A. Faces Class Action: Investor Insights and More
• Revolutionizing DeFi: aPriori's Insights on Latency Challenges
• Understanding the Implications of Recent Mergers for Shareholders
• Legal Inquiry: Mergers and Acquisitions Affecting Shareholders
• LivePerson Announces Recent Equity Incentive Awards Details
• Exciting New Travel Deals Released by Travelzoo for Members
• Kinross Gold Corporation Completes Sale of White Gold Shares
• Investigation Launched for Data Breach Impacting NASCAR Fans
• Easterly ROCMuni Fund Faces Legal Scrutiny: Investor Alert
• Urgent Notice for XPLR Infrastructure Investors: Act Now
• Discover Magnite's Impressive Growth Over the Past 5 Years
• PharmAla Biotech Expands Operations with Strong Q3 Results
• Discover the Innovative GREY'S ANATOMY™ EMERGE Collection Today
• Nabors Industries Welcomes David Tudor to the Board of Directors
• Edelson Lechtzin LLP Investigates Premier Health Data Breach
• U.S. Strengthens Trade Laws Against Unfair Lumber Practices
• Berklee College of Music Honors Oliver Charles with Scholarship
• ECN Capital Plans Conference Call for Q2-2025 Financials
• Barnes & Noble Education Faces Legal Inquiry into Stock Practices
• Eshallgo Inc. Faces Nasdaq Compliance Challenge Ahead
• Class Action Alert for Rocket Pharmaceuticals Investors
• Fairfax Financial Hosts Conference Call for Second Quarter Insights
• ECN Capital Plans to Discuss Second Quarter 2025 Results
• PharmAla Reports Impressive Growth and Key Milestones Achieved
• Legal Action on Behalf of XPLR Infrastructure Unit Holders